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Background Epidemiological and clinical data of human
coronaviruses (HCoVs) infections are restricted to span 1–3 years
at most. We conducted a comprehensive 9-year study on HCoVs by
analyzing 1137 respiratory samples from four subsets of patients
(asymptomatic, general community, with comorbidities, and
hospitalized) in S~ao Paulo, Brazil.
Methods A pan-coronavirus RT-PCR screening assay was
performed, followed by species-specific real-time RT-PCR
monoplex assays.
Results Human coronaviruses were detected in 88 of 1137 (7.7%)
of the samples. The most frequently detected HCoV species were
NL63 (50.0%) and OC43 (27.3%). Patients with comorbidities
presented the highest risk of acquiring coronavirus infection (odds
ratio = 4.17; 95% confidence interval = 1.9–9.3), and children with
heart diseases revealed a significant HCoV infection presence.
Dyspnea was more associated with HCoV-229E infections (66.6%),
and cyanosis was reported only in HCoV-OC43 infections. There
were interseasonal differences in the detection frequencies, with
HCoV-229E being predominant in the year 2004 (61.5%) and
HCoV-NL63 (70.8%) in 2008.
Conclusions Our data provide a novel insight into the
epidemiology and clinical knowledge of HCoVs among different
subsets of patients, revealing that these viruses may cause more than
mild respiratory tract disease.
Keywords Clinical features, epidemiology, human coronaviruses,
respiratory infection.
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Introduction
The genus Coronavirus belongs to the family Coronaviridae in
the order Nidovirales. Coronaviruses (CoVs) infect a variety
of livestock, poultry, and companion animals, in which they
can cause serious and often fatal respiratory, enteric,
cardiovascular, and neurological diseases.1 The first reports
on human coronaviruses (HCoVs) appeared in the mid-
1960s. The human viruses were isolated from persons with
the common cold, and two species were detected: HCoV-
229E and HCoV-OC43.2
Almost 40 years later, an emergent HCoV was identified
as the causative agent of severe acute respiratory syndrome
(SARS).3 While SARS-CoV was eradicated from the human
population after a highly effective global public health
response,4 its emergence necessitated a rethinking of the
role that CoVs play as a potential cause of more than just
the common cold. Thereafter, there was an increase in
research on HCoVs worldwide, which has led to the
discovery of two other HCoVs, HCoV-NL63 in the
Netherlands and HCoV-HKU1 in China.5,6 Reports have
documented that HCoVs are involved in a wide spectrum
of clinical presentation in upper and lower respiratory tract
illnesses,7–15 as well as being a contributor to exacerbations
of chronic obstructive pulmonary disease16 and among
patients presenting cystic fibrosis.17 The involvement of
other non-respiratory organ systems is still controversial
but can occur, for example the enteric and nervous
systems.18,19 Additionally, the role of HCoV infections
among susceptible groups, outbreaks, and fatal cases has
been documented.20–25 However, the majority of reports
describe HCoV infections only among children. Moreover,
longitudinal studies of CoV epidemiology in the literature
are lacking and are restricted to descriptions spanning
1–3 years at most.26–28 In this study, we conducted a
comprehensive 9-year study of the epidemiological and
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clinical features of all four circulating HCoVs (OC43, 229E,
HKU1, and NL63) among four different subsets (asymp-
tomatic, general community, with comorbidities, and
hospitalized) of adult and child patients.
Material and methods
Study design and population
During the 9-year study, respiratory samples were collected
from patients presenting acute respiratory illnesses and those
who were asymptomatic. The study period began in June
2001 and concluded in September 2010. We collected 1137
samples and stored them at 80°C. The clinical specimens
from the studied patients were collected from specific units
by trained professionals (nurses or doctors). The specimens
comprised 464 nasopharyngeal swabs, 208 nasal aspirations,
and 465 nasal lavages. The subjects were 50 asymptomatic
adults and 1087 patients presenting acute respiratory infec-
tions (ARIs): 465 from the general community (adults,
children, and healthcare workers), 410 with comorbidities
(children with heart diseases, patients with stem cell and
renal transplants), and 212 hospitalized patients (adults and
children) originally suspected of H1N1 2009 influenza
infection. Of the 1137 studied patients, 591 (51.9%) were
adults, while the rest were children. The patients were treated
at the primary care health service section of S~ao Paulo
Federal University/S~ao Paulo University Hospital in ambu-
latory or specific units and the emergency room. Each of
these specific health services had a variable flow of sampling
to respiratory viruses diagnoses, which resulted in collections
of different patient groups in this study. Hence, the subjects
groups were unevenly distributed throughout the study. The
distribution of the studied years and clinical specimens by
studied patients is shown in Table 1.
Inclusion criteria
The inclusion criteria were as follows: clinical diagnosis of
influenza-like illness (ILI) defined by the presence of fever
plus at least one respiratory symptom (cough and/or sore
throat) and one constitutional symptom (headache, myalgia,
sweat, or chills); clinical diagnosis of ARI, defined by the
presence of respiratory symptoms that did not fulfill the
definition of ILI; hospitalized patients suspected of 2009
H1N1 influenza A infection presenting fever >38°C, cough,
and dyspnea. Lower respiratory tract illness was defined as
having suggestive clinical findings and one of the following:
chest radiograph revealing possible or definite infiltrates,
mechanical ventilation requirement, or supplemental oxygen
requirement.
Demographic and clinical data
Epidemiological and clinical data from outpatients were
obtained using a standardized questionnaire, while data from
hospitalized patients were extracted from medical charts
using a standardized form. Age, gender, occupation, presence
of underlying conditions or diseases, and clinical findings at
first attendance (for outpatients) or during the first 24 hours
(for hospitalized patients) were recorded for analysis. The
number of days between admission and a positive CoV
sampling, as well as the total length of respiratory illness, was
evaluated for evidence of nosocomial acquisition. Institu-
tional review board approval was received before we reviewed
any records. The Ethics Committee of S~ao Paulo Federal
University (CEP 1968/09) approved this study, and written
Table 1. Distribution of studied patients by year and clinical specimen
Populations Tested, no.
Years
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 Specimen
Adults* 50 ● ● ● NL
Healthcare workers* 86 ● ● ● NL
Children* 329 ● ● ● NPS
Children with heart diseases† 81 ● ● ● NA
Renal transplant patients† 148 ● ● ● NL
ST transplantation program† 181 ● ● NL
Hospitalized 212 ● ● NPS
Asymptomatic subjects 50 ● NPS
Total samples 1137 45 76 67 96 42 3 20 231 370 187
●, Sampling.
NL, nasal lavage; NPS, nasopharyngeal swab; NA, nasal aspiration; ST, stem cell.
*Patients from the community.
†Patients with comorbidities.
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consent was obtained from all patients or those responsible
for the individual patient.
Pan-CoV RT-PCR one-step assay
Viral genomic RNA was extracted from the collected
specimens with a QIAamp Viral RNA extraction kit (Qiagen,
Valencia, CA, USA) according to the manufacturer’s instruc-
tions. A previously described pan-CoV RT-PCR assay29 with
minor modifications (from 50 amplification cycles to 40 and
melting temperature from 48 to 50°C) was performed as a
screening step to detect human and animal CoVs in the
samples. The amplification of a 251-bp fragment of the
polymerase gene was carried out using the following primer
set: Cor-FW (5′-ACWCARHTVAAYYTNAARTAYGC-3′)
and Cor-RV (5′-TCRCAYTTDGGRTARTCCCA-3′). These
one-step RT-PCR assays (OneStep RT-PCR kit; Qiagen) were
undertaken in a 50-ll reaction volume containing 10 ll RNA
extract, 10 ll 5 9 Qiagen OneStep RT-PCR Buffer, 2 lL
dNTP mix (final concentration of 400 lM of each dNTP),
1.8 ll Qiagen OneStep RT-PCR Enzyme Mix (a combination
of Omniscript and Sensiscript reverse transcriptase and
HotStarTaq DNA polymerase), 4 lM of each primer, and
RNase-free water. Positive and negative controls were
included in each PCR experiment. The reaction was carried
out with an initial reverse transcription step at 50°C for
30 minutes, followed by PCR activation at 95°C for
15 minutes, 40 cycles of amplification (30 seconds at 94°C;
30 seconds at 50°C; 1 minutes at 72°C), and a final extension
step at 72°C for 10 minutes in a Veriti thermal cycler
(Applied Biosystems, Foster City, CA, USA). PCR products
were verified on an agarose gel, stained with ethidium
bromide, and visualized under UV light. The sensitivity of
the assay was assessed by testing 10-fold dilutions of HCoV-
NL63 RNA standard curve, which showed sensitivity of
5 9 105 RNA copies/ll. The specificity was assessed by
testing controls of other respiratory viruses (rhinovirus,
bocavirus, human parainfluenza 1, 2, and 3, influenza A and
B, metapneumovirus, adenovirus, and respiratory syncytial
virus) through the methods for HCoVs detection. There was
no amplification of the non-HCoV controls through the
method used for CoVs detection.
Real-time RT-PCR for HCoV detection
Positive samples on the pan-CoV RT-PCR assay were tested
to identify the HCoV species OC43, 229E, NL63, and HKU1
using a previously described real-time RT-PCR panel con-
sisting of four different HCoV monoplex assays run under
identical amplification conditions. Reaction mixtures were
prepared using the AgPath-IDTM One-Step RT-PCR Kit
(Applied Biosystems). Reactions (25 ll) contained 2 9 RT-
PCR buffer, 25 9 RT-PCR enzyme mix, primers, probe,
nuclease-free water, and nucleic acid. Amplification was
performed on a 7500 Standard Real-Time PCR System
(Applied Biosystems) with the following cycling conditions:
48°C for 10 minutes (1 cycle); 95°C for 5 minutes (1 cycle);
and 95°C for 15 seconds followed by 55°C for 1 minutes (45
cycles). Each specimen was also tested for the human
ribonuclease P gene to measure nucleic acid integrity.30 The
sensitivity of the assay was assessed by testing 10-fold
dilutions of each HCoVs RNA standard curve, which showed
sensitivity of 5 9 102 copies/ll for HCoV-OC43, 5 9 104
copies/ll for HCoV-229E, 5 9 103 copies/ll for HCoV-
NL63, and 5 9 103 copies/ll for HCoV-HKU1. The speci-
ficity was assessed as described in the Pan-CoV assay.
Statistical analysis
Statistical analysis consisted of Pearson’s v2 test for the
comparison of categorical values, with a significance level of
P < 0.05. Non-conditional logistic regression was used to
identify associations between CoV positivity and the studied
populations. All reported values were two-tailed. Results are
presented as odds ratios (OR) and the respective 95%
confidence intervals (CI), and P values. All data were
analyzed using the Statistical Analysis Software, version 9.0
(SAS Institute Inc., Cary, NC, USA).
Results
Coronavirus detection
The pan-CoV assay detected 128/1137 (11.2%) CoV-positive
samples, and the real-time RT-PCR panel identified 88 HCoV
of the 128 (68.7%) screened samples. The most frequently
detected HCoV species were NL63 (50.0%) and OC43
(27.3%). The 229E and HKU1 species were detected in 17.0
and 5.7% of the samples, respectively. The CoV infection
among the studied settings was evaluated by logistic regres-
sion analysis. When compared with the hospitalized, signif-
icant difference (P < 0.05) was observed among all subsets,
except in children from the community (P = 0.3076) and
asymptomatics (P = 0.9879; Table 2). Patients with comor-
bidities presented the highest risk of acquiring CoV infection
(OR = 4.17; 95% CI 1.9–9.3; P = <0.05) when compared
with the other subsets. Children with heart diseases and renal
transplant patients had the next highest rates of CoV
infections after the comorbidities group, tallying 17.3 and
12.2%, respectively. An important rate of detection was also
found among healthcare workers (10.5%) and patients in
stem cell transplantation programs (10.5%). No HCoV
infection was found among asymptomatic patients. Figure 1
illustrates the distribution of HCoV species among the
positive cases based on the studied patient subsets. HCoV-
NL63 was the species most frequently associated with
children, both from the community (100%) and presenting
heart diseases (50%), while there was a high rate of HCoV-
229E detection among renal transplant patients (44%).
Patients in stem cell transplantation programs were more
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frequently infected with HCoV species OC43 (47%) and
NL63 (42%) when compared with the other HCoV species.
HCoV-NL63 was not detected among adults from the
community, and HCoV-HKU1 was detected only among
adults, healthcare workers, and children with heart diseases.
Circulation trend
Coronaviruses were most frequently detected during winter
and autumn (75%) (Figure 2). Peak detection frequency was
observed in the years 2001, 2004–2005, and 2008, with the
highest rate of detection recorded in 2005 (8/42; 19%). There
were additional longer-term differences in detection fre-
quencies between seasons, with HCoV-229E being predom-
inant in 2004 (61.5%) and HCoV-NL63 (70.8%) in 2008.
HCoV-OC43 was detected in all studied years (except in
2006, when no CoV cases were detected) from March to
November (autumn to spring), with detection frequencies
peaking in August (winter). Interseason HCoV-OC43 detec-
tion frequencies were more consistent than that for the other
CoVs.
HCoV-HKU1 was detected only in July (winter) of 2001,
2005, and 2008. A decrease in HCoV-OC43 detection was
observed during the period of HCoV-HKU1 detection.
HCoV-229E displayed a marked autumn seasonality
(between March and April), with the highest rate of detection
recorded in May (autumn) in 2002, 2004–2005, and 2008–
2010.
HCoV-NL63 was the most frequently detected species in
the study, circulating in all seasons. Although the NL63
species presented a high frequency of detection in July
(winter), it was a unique HCoV species with cases also being
detected in the summer.
Patient parameters
The median age of HCoV-infected patients was 28 years
(range, 1 month to 68 years). The frequency was higher in
patients aged 50–59 years (15.9%). Figure 3 depicts the
distribution of CoV-infected cases by age. Predominantly,
infected patients were female (60 9 28, P < 0.001). Sixteen
percent (16/88) of the infected patients reported underlying
conditions such as human immunodeficiency virus (HIV)
and human T-cell leukemia virus (HTLV)-type infection,
diabetes mellitus, liver transplant, megacolon syndrome,
hypertension, Wiskott–Aldrich syndrome, and congenital
kidney and lung diseases. In addition, four patients were
born prematurely and seven were smokers.
Clinical associations of CoV infections
Clinical data were available for all 88 HCoV-infected patients
(Table 3). Coryza, cough, and fever were the most common
symptoms at presentation, being reported in 86%, 77%, and
51% of positive cases, respectively. There were differences in
clinical expression among the studied populations. Fever was
found less frequently among renal transplant patients and
patients in stem cell transplantation programs when com-
pared with the other patient subsets. Cyanosis was observed
among children with heart disease, and wheezing was
reported among hospitalized patients, children from the
community, and children with heart diseases. Dyspnea,
another lower respiratory tract infection symptom other than
wheezing, was documented among patients in stem cell
transplantation programs, children with heart diseases,
children from the community, and hospitalized patients.
Healthcare workers presented more cases of sore throat and
myalgia than did adults from the community group, patients
under transplantation program, and hospitalized patients.
Differences in clinical presentation were observed among
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Figure 1. Proportions of samples positive for each human coronavirus
from subsets of studied patients. HCW, healthcare workers; Com child,
children from the community; Renal TP, renal transplant patients; Child
heart, children with heart diseases; Stem cel TP, patients in stem cell
transplantation programs; Hosp, hospitalized.
Table 2. Detection of HCoVs over 9 years from 1137 samples
Populations
Tested
no.
Detection
rate* P value
Adults† 50 4 (8%) <.0001
Healthcare workers† 86 9 (10.5%) 0.0183
Children† 329 17 (5.2%) 0.3076
Children with heart diseases‡ 81 14 (17.3%) 0.0002
Renal transplant patients‡ 148 18 (12.2%) 0.0023
ST transplantation program‡ 181 19 (10.5%) 0.006
Hospitalized 212 7 (3.3%) ref
Asymptomatic subjects 50 0 (0%) 0.9879
Total 1137 88 (7.7%) –
ST, stem cell; HCoVs, human coronaviruse.
*Real-time RT-PCR for human coronavirus detection.
†Patients from the community.
‡Patients with comorbidities.
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each HCoV species infection (Figure 4). Patients infected
with HCoV-HKU1 presented more fever, coryza, and
myalgia when compared with the other HCoV-infected cases
(P < 0.05). Dyspnea was more frequently associated with
patients infected with HCoV-229E (66.6%). Cyanosis was
reported only among patients infected with HCoV-OC43,
and diarrhea was reported only in HCoV-NL63 cases.
The median time for hospitalized CoV-infected patients to
be discharged was 12 days (range, 5–30 days); of the seven
hospitalized CoV-infected patients, three were infected with
HCoV-NL63, two with HCoV-229E, and the other two with
HCoV-OC43. Patients infected with HCoV-OC43 stayed
longer in hospital (average, 19 days) than did patients
infected with HCoV-NL63 or HCoV-229E. Four hospitalized
patients of seven (57.1%) were admitted to the intensive care
unit. Lower respiratory tract infections were found in 6/7
(85.7%) hospitalized CoV-infected patients. The remaining
patient was infected by HCoV-OC43 and presented upper
respiratory tract infection. This patient was a nosocomial
case documented in a child who had been admitted for an
intestinal surgery due to megacolon. Six of the patients had a
good outcome, but 1 diabetic adult died of HCoV-NL63-
associated pneumonia 9 days after admission.
Coinfections
Investigations into other respiratory viruses (rhinovirus,
bocavirus, human metapneumovirus, adenovirus, influenza
A or B, and respiratory syncytial virus) were available in 87 of
88 CoV-infected cases, in which at least 1 respiratory virus
other than CoV was detected in 26 samples (29.8%).
Rhinovirus (46.1%) and adenovirus (26.9%) were the most
frequently codetected viruses in CoV-positive cases. HCoV-
NL63 was associated most frequently with coinfection
(57.7%), followed by HCoV-229E (23.1%) and HCoV-
OC43 (19.2%). There was no codetection of HCoV-HKU1
with other respiratory viruses. The most common associa-
tions were HCoV-NL63 plus adenovirus (46.1%) and HCoV-
NL63 plus rhinovirus (38.5%). The methods used for
detecting the coinfections were conventional RT-PCR (for
rhinovirus, bocavirus, and human metapneumovirus detec-
tion) and direct immunofluorescence (adenovirus, influenza
A or B, and respiratory syncytial virus detection).
Discussion
Since the emergence of SARS-CoV, numerous studies have
been carried out on the clinical impact of different HCoV
species.8,9,13,14,16,26–28,30–32 However, the majority of these
studies were only performed in children, with small sample
sizes and short sample collection periods. This is the first
study reporting on the epidemiological and clinical features
of non-SARS HCoV infections among different clinical
patient subsets, both adult and child, over a 9-year period.
Human coronaviruses were detected among all studied
subjects presenting respiratory tract illnesses, but not among
those who were asymptomatic. Recently, studies have
demonstrated HCoV detection among asymptomatic
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Figure 2. Human coronavirus detection
frequencies by month over 9 years.
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coronaviruses by age.
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patients, with a positive rate of approximately 4–7%.33,34 In
contrast to our study, the evaluated asymptomatic patients
from those reports were children, and we hypothesize that
asymptomatic respiratory infection may be more frequent
among children than in adults.
An important CoV detection rate was found among the
subset of patients with comorbidities, being most frequent in
children with heart diseases and in renal transplant patients.
Additionally, underlying conditions other than cardiac
disease/transplantation were observed in 18% of CoV-
infected patients. These data point to the relevance of CoVs
causing respiratory tract illness in patients with comorbid-
ities. Some reports have demonstrated a correlation between
CoV-induced respiratory tract illness and populations with
comorbidities.22,35–37
In spite of there being a lower HCoV detection rate in the
hospitalized subset, the majority of positive cases presented
with lower respiratory tract infections, and one fatal case was
documented. This result supports the premise that HCoV
infection may cause more than mild respiratory tract disease.
A significant frequency of HCoVs among healthcare
workers was also documented. Previous studies have dem-
onstrated the important burden of healthcare workers
associated with respiratory tract infections, as well as their
being strongly implicated in HCoV outbreaks.20,25,38–40
Although HCoV is considered one of the most common
respiratory viruses associated with respiratory tract infections
in children, the present study revealed a higher rate of
detection among adults in the 50- to 59-year range. As our
study cohort contained a significant number of adult patients
with comorbidities, this result can represent a bias.
As different age groups were tested for HCoV infections in
different years in our study, this represents a flaw in the study
design which prevents us from comparing the frequency of
infection in one age group to another, and it is considered as
the major limitation of this work. Nevertheless, the results of
our study showed interesting findings on HCoVs infection,
which means that HCoVs may be the causal agents of
respiratory diseases among patients under different clinical
conditions, either adults or children.
Our data revealed that NL63 and OC43 were the most
commonly detected HCoV species in our study. Recently,
Dijkman et al.41 demonstrated that HCoV-OC43 and
HCoV-NL63 may elicit immunity that protects from
subsequent HCoV-HKU1 and HCoV-229E infection, respec-
tively, which would explain why HCoV-OC43 and HCoV-
NL63 are the most frequently infecting HCoVs. Other
studies have demonstrated a higher frequency of
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Figure 4. Distribution of symptoms by each human coronaviruse-
infected case.
Table 3. Clinical data of CoV-infected patients, 2001–2010
Symptoms
Populations
Adults (%) HCW (%) Com child (%) Child heart (%) Renal TP (%) Stem cel TP (%) Hospitaliz (%)
Fever 100.0 55.5 64.7 50.0 16.6 42.1 100.0
Cough 100.0 44.4 88.2 85.7 66.6 73.7 100.0
Wheezing – – 31.2 41.6 – 0 28.6
Cyanosis – – 0.0 7.1 – 0 0
Dyspnea – – 23.5 35.7 – 26.3 71.4
Coryza 100.0 100.0 100.0 85.7 88.8 78.9 42.8
Sore throat 50.0 55.5 – – 33.3 21.0 16.6
Headache 100.0 77.7 – – 50.0 15.8 28.6
Diarrhea 0.0 0.0 0.0 0.0 0 0.0 16.6
Myalgia 75.0 77.7 – – 27.7 21.0 14.3
–, Not evaluated.
HCW, healthcare workers; Com child, children from the community; Child heart, children with heart diseases; Renal TP, renal transplant patients;
Stem cel TP, patients in stem cell transplantation programs; Hospitaliz, hospitalized; CoV, coronavirus.
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HCoV-NL63 among children12,32,42 and HCoV-OC43
among adults.43
Although it is possible to verify the periodicity of HCoVs
infection in the presented data of this study, that is, HCoV-
HKU1 (Figure 2), our study focuses on HCoV-type speci-
ficity frequency in particular patient groups. In this regard,
HCoV-229E was mainly associated with renal transplant
patients and HCoV-NL63 was involved in a death. HCoV-
229E has previously been associated with infections in
immunocompromised individuals,37,44 and some reports
have demonstrated the further association of HCoV-NL63
with fatal cases.22–24 However, there are no consistent
indications that infection by one HCoV is more pathogenic
than that with another. Thus, our data provide evidence that
the detection and diagnosis of HCoV infections should be
considered for immunocompromised individuals with
respiratory tract symptoms.
Coronaviruses display the marked seasonality typical of
other respiratory viruses, with high detection frequencies in
the winter months but few or no detections in the summer.
The climate of the city of Sao Paulo (Southeast of Brazil) is
under constant influence of both the southern coast and the
northern part of the state, which presents a subtropical
climate. Thus, this city has an uncharacterized climate
marked by a wide thermal and meteorological variety. In this
regard, it is not possible for us to trace any interaction
between climatic and meteorological factors and HCoVs
detection. However, due to the long-term HCoV surveillance
performed in the present study, it was possible to demon-
strate particular trends concerning CoV species seasonality,
where different marked peaks of detection were observed for
each HCoV species during the 9-year study. Other studies
have demonstrated differences between CoV species season-
alities and a winter preference. van der Hoek et al.45
performed a study on HCoV-NL63 revealing that this species
infection follows a 2-year interepidemic period with peaks of
infection in the winters. Gaunt et al.28 in a study carried out
over a period of 3 years in the UK demonstrated a high
detection of HCoVs species during winter months.
Our study showed a very low HCoVs detection rate in
2007 and none in 2006. These were the years that presented
the lowest number of samples included in the study, and we
believe this might have influenced the HCoVs detection
during these 2 years.
Different clinical specimens were used in search of HCoVs.
Although some studies have shown the sensitivity of different
kinds of specimens for respiratory viruses diagnosis through
many different detection methods, we did not evaluate data
on HCoVs detection from the different specimens collected
using the molecular methods applied in our study.
In conclusion, our data provide a novel insight into the
epidemiology and clinical knowledge of HCoV among
different subsets of patients, supporting the notion that
HCoVs play an important role among patients with comor-
bidities. HCoV infections were found not only in children,
but also among adults, mainly in healthcare workers.
Therefore, HCoVs are important pathogens involved in
unexplained respiratory illness among patients with different
clinical patterns.
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